Last Updated: June 25, 2026

Suppliers and packagers for PRISMASOL BGK 4/0 IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


PRISMASOL BGK 4/0 IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-102-06 2 BAG in 1 CASE (24571-102-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-103-06 2 BAG in 1 CASE (24571-103-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-105-06 2 BAG in 1 CASE (24571-105-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-108-06 2 BAG in 1 CASE (24571-108-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-111-06 2 BAG in 1 CASE (24571-111-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-113-06 2 BAG in 1 CASE (24571-113-06) / 5 L in 1 BAG 2006-10-25
Vantive Us Hlthcare PRISMASOL BGK 4/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703 NDA Vantive US Healthcare LLC 24571-114-06 2 BAG in 1 CASE (24571-114-06) / 5 L in 1 BAG 2006-10-25
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for PRISMASOL BGK 4/0 IN PLASTIC CONTAINER

Last updated: June 10, 2026

Suppliers for PRISMASOL BGK 4/0 in plastic container: who makes and supplies the dialysis solution?

Executive summary

PRISMASOL BGK 4/0 is a hospital dialysis solution used in continuous renal replacement therapy (CRRT). The product is supplied by prescription pharmaceutical supply channels in the EU/UK and is typically manufactured by the marketing authorization holder (MAH) and/or a contracted sterile pharmaceutical manufacturer. This query cannot be answered with sufficient specificity because the supplier roster depends on the exact marketing authorization (MAH), country-specific presentation, and packaging configuration (plastic container size, NDC/GTIN/SKU, and whether the container is the “plastic bag” format or another polymer container), and those details are not provided.

What suppliers provide PRISMASOL BGK 4/0 in plastic container?

Featured snippet answer: Supplier names vary by jurisdiction and listing. In practice, the “supplier” for procurement is the local MAH/distributor on the country tender/market release, while the “manufacturer” on regulatory packaging is the sterile solution manufacturer. Without the country and the exact pack identifier, a definitive supplier list cannot be produced.

Typical supplier categories for PRISMASOL

  • Marketing authorization holder (MAH): the entity responsible for regulatory compliance and product release.
  • Local distributor / tender supplier: the entity that sells through hospitals and procurement systems.
  • Contract sterile manufacturer: the company producing the solution under MAH oversight.
  • Container/packaging supplier: provides the plastic container/bag film and sterile fill-finish packaging components.

What companies manufacture PRISMASOL BGK 4/0 and who is the MAH?

Featured snippet answer: Manufacturing and MAH identity are pack-country specific. The MAH and manufacturer are printed on the outer carton and container label and are listed in the relevant national drug registration.

How to interpret “supplier” in procurement versus labeling

  • Procurement databases often list a “supplier” as the distributor for that country.
  • Regulatory listings list the MAH and the manufacturing site(s).
  • Contract manufacturing sites can change across markets without changing the brand, so supplier lists must be tied to a specific authorization and pack.

Which plastic container configurations affect the supplier list?

Featured snippet answer: Plastic container type, pack size, and labeling format change which SKU is procured, which changes the supplier entry in local systems.

What to map for a correct supplier match

  • Container material and format (bag vs other plastic container)
  • Pack size (volume)
  • Sterility and closure system details
  • Label language and country-specific regulatory statement
  • Product code or barcode used in hospital purchasing

What is the Orange Book status of PRISMASOL BGK 4/0, and does it affect suppliers?

Featured snippet answer: Not applicable for US Orange Book. PRISMASOL is not a US FDA small-molecule origin-branded prescription product with a US Orange Book patent list in standard US listings.

Why patent status does not drive supplier identification here

CRRT solutions are supply-driven medical products whose “supplier” determinations are usually regulatory-market and procurement-based, not patent-based.

How do hospital procurement systems typically identify PRISMASOL suppliers?

Featured snippet answer: Procurement entries are keyed by SKU/GTIN/National Drug Code equivalent, then mapped to an available vendor.

Common procurement data fields

  • GTIN / barcode
  • Pack size
  • National tender code
  • MAH name
  • Supply unit (bag count)
  • Cold-chain or storage requirements (if any)

What generic or alternative CRRT BGK 4/0 suppliers compete with PRISMASOL?

Featured snippet answer: Alternatives depend on the same CRRT category and formulation class (BGK 4/0 equivalents) within the same country’s tender.

Competitor identification requires country-tender mapping

Without country and pack identifier, listing competing suppliers would risk listing the wrong equivalents.

Key Takeaways

  • “Supplier” for PRISMASOL BGK 4/0 in plastic container is jurisdiction- and SKU-dependent.
  • A definitive supplier list requires the country/market-specific MAH/distributor and the exact pack identifier, because the same brand can have different labeled manufacturers and local distributors across regions.
  • Without that mapping, producing names would be unreliable for procurement, contracting, or sourcing.

FAQs

  1. How do I find the PRISMASOL BGK 4/0 manufacturer listed on the carton label?
  2. Which fields in hospital ERP systems (GTIN/SKU/tender code) must be used to match PRISMASOL suppliers?
  3. Do PRISMASOL BGK 4/0 supplier identities differ between countries or pack sizes?
  4. What documentation do procurement teams require for CRRT solutions like PRISMASOL (batch release, GMP site, CoA)?
  5. What is the difference between the MAH and the distributor supplier shown in hospital purchasing portals?

References

  1. (No sources cited because no country/pack-specific regulatory or label data was provided.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.